AAPL314.14-2.08 (-0.66%) ▼|ABBV246.21-3.71 (-1.48%) ▼|ABT93.80-0.60 (-0.64%) ▼|ACN135.74-3.33 (-2.39%) ▼|ADBE223.11+0.46 (+0.20%) ▲|AMAT607.27+18.61 (+3.16%) ▲|AMD558.03+11.31 (+2.07%) ▲|AMGN361.52-2.10 (-0.58%) ▼|AMT167.24+2.24 (+1.35%) ▲|AMZN245.07-1.98 (-0.80%) ▼|AVGO399.73-1.39 (-0.35%) ▼|AXP350.20+3.48 (+1.00%) ▲|BA222.54-0.57 (-0.26%) ▼|BAC59.80+0.55 (+0.92%) ▲|BKNG178.45+2.93 (+1.67%) ▲|BLK1,035.05+15.37 (+1.51%) ▲|BMY57.29-0.65 (-1.11%) ▼|BNY151.89-0.37 (-0.24%) ▼|BRK-B492.62-2.83 (-0.57%) ▼|C140.99+1.42 (+1.01%) ▲|CAT956.59+18.20 (+1.94%) ▲|CL92.25+1.24 (+1.36%) ▲|CMCSA23.45+0.10 (+0.43%) ▲|COF201.16+1.06 (+0.53%) ▲|COP108.15+0.13 (+0.12%) ▲|COST914.50+1.53 (+0.17%) ▲|CRM162.92+0.42 (+0.26%) ▲|CSCO120.44+2.13 (+1.80%) ▲|CVS104.20+1.39 (+1.35%) ▲|CVX174.66+0.61 (+0.35%) ▲|DE592.71-0.20 (-0.03%) ▼|DHR198.07+2.09 (+1.07%) ▲|DIS96.01-0.16 (-0.17%) ▼|DUK124.95-0.31 (-0.25%) ▼|EMR139.62+1.82 (+1.32%) ▲|FDX314.22+3.38 (+1.09%) ▲|GD373.66-0.94 (-0.25%) ▼|GE359.96+0.92 (+0.26%) ▲|GEV1,100.30+25.04 (+2.33%) ▲|GILD129.90-4.94 (-3.66%) ▼|GM78.49+1.84 (+2.40%) ▲|GOOG353.04-3.20 (-0.90%) ▼|GOOGL355.32-3.57 (-0.99%) ▼|GS1,058.81+2.84 (+0.27%) ▲|HD343.02+4.29 (+1.27%) ▲|HON227.40+3.98 (+1.78%) ▲|IBM289.49-5.81 (-1.97%) ▼|INTC110.16-2.38 (-2.11%) ▼|INTU273.31-0.07 (-0.03%) ▼|ISRG403.94-7.61 (-1.85%) ▼|JNJ256.32-2.78 (-1.07%) ▼|JPM336.54+1.07 (+0.32%) ▲|KO83.35+0.72 (+0.87%) ▲|LIN531.55+5.99 (+1.14%) ▲|LLY1,183.88-33.07 (-2.72%) ▼|LMT519.46+1.20 (+0.23%) ▲|LOW213.23+0.23 (+0.11%) ▲|LRCX353.44+0.27 (+0.08%) ▲|MA521.38-1.83 (-0.35%) ▼|MCD276.75+0.26 (+0.09%) ▲|MDLZ58.72+0.42 (+0.71%) ▲|MDT83.55+1.16 (+1.41%) ▲|META668.23+36.75 (+5.82%) ▲|MMM157.80+2.46 (+1.58%) ▲|MO71.60+0.01 (+0.01%) ▲|MRK123.20-1.87 (-1.50%) ▼|MS222.61+0.48 (+0.21%) ▲|MSFT383.94-0.42 (-0.11%) ▼|MU991.99+0.35 (+0.04%) ▲|NEE87.26+0.16 (+0.18%) ▲|NFLX73.18-2.29 (-3.03%) ▼|NKE44.58+1.80 (+4.20%) ▲|NOW107.16-1.69 (-1.55%) ▼|NVDA210.20+7.42 (+3.66%) ▲|ORCL141.45-2.27 (-1.58%) ▼|PEP137.05-0.81 (-0.59%) ▼|PFE24.25+0.00 (+0.00%) ▲|PG147.09+0.24 (+0.16%) ▲|PLTR126.68-2.37 (-1.83%) ▼|PM180.81-0.36 (-0.20%) ▼|QCOM189.18-1.93 (-1.01%) ▼|RTX195.68+0.48 (+0.25%) ▲|SBUX106.96+0.55 (+0.52%) ▲|SCHW102.66+0.75 (+0.74%) ▲|SO95.34+0.17 (+0.17%) ▲|SPG215.88-3.84 (-1.75%) ▼|T21.13+0.36 (+1.75%) ▲|TMO524.82+0.11 (+0.02%) ▲|TMUS185.86+4.38 (+2.41%) ▲|TSLA409.88+3.33 (+0.82%) ▲|TXN311.48+2.95 (+0.96%) ▲|UBER74.78+0.43 (+0.58%) ▲|UNH424.78-6.90 (-1.60%) ▼|UNP288.49+3.45 (+1.21%) ▲|UPS112.67+1.93 (+1.74%) ▲|USB62.59+0.69 (+1.11%) ▲|V346.68-1.53 (-0.44%) ▼|VZ42.29+0.75 (+1.81%) ▲|WFC87.17+0.26 (+0.30%) ▲|WMT113.75+1.54 (+1.37%) ▲|XOM137.91+0.45 (+0.32%) ▲|AAPL314.14-2.08 (-0.66%) ▼|ABBV246.21-3.71 (-1.48%) ▼|ABT93.80-0.60 (-0.64%) ▼|ACN135.74-3.33 (-2.39%) ▼|ADBE223.11+0.46 (+0.20%) ▲|AMAT607.27+18.61 (+3.16%) ▲|AMD558.03+11.31 (+2.07%) ▲|AMGN361.52-2.10 (-0.58%) ▼|AMT167.24+2.24 (+1.35%) ▲|AMZN245.07-1.98 (-0.80%) ▼|AVGO399.73-1.39 (-0.35%) ▼|AXP350.20+3.48 (+1.00%) ▲|BA222.54-0.57 (-0.26%) ▼|BAC59.80+0.55 (+0.92%) ▲|BKNG178.45+2.93 (+1.67%) ▲|BLK1,035.05+15.37 (+1.51%) ▲|BMY57.29-0.65 (-1.11%) ▼|BNY151.89-0.37 (-0.24%) ▼|BRK-B492.62-2.83 (-0.57%) ▼|C140.99+1.42 (+1.01%) ▲|CAT956.59+18.20 (+1.94%) ▲|CL92.25+1.24 (+1.36%) ▲|CMCSA23.45+0.10 (+0.43%) ▲|COF201.16+1.06 (+0.53%) ▲|COP108.15+0.13 (+0.12%) ▲|COST914.50+1.53 (+0.17%) ▲|CRM162.92+0.42 (+0.26%) ▲|CSCO120.44+2.13 (+1.80%) ▲|CVS104.20+1.39 (+1.35%) ▲|CVX174.66+0.61 (+0.35%) ▲|DE592.71-0.20 (-0.03%) ▼|DHR198.07+2.09 (+1.07%) ▲|DIS96.01-0.16 (-0.17%) ▼|DUK124.95-0.31 (-0.25%) ▼|EMR139.62+1.82 (+1.32%) ▲|FDX314.22+3.38 (+1.09%) ▲|GD373.66-0.94 (-0.25%) ▼|GE359.96+0.92 (+0.26%) ▲|GEV1,100.30+25.04 (+2.33%) ▲|GILD129.90-4.94 (-3.66%) ▼|GM78.49+1.84 (+2.40%) ▲|GOOG353.04-3.20 (-0.90%) ▼|GOOGL355.32-3.57 (-0.99%) ▼|GS1,058.81+2.84 (+0.27%) ▲|HD343.02+4.29 (+1.27%) ▲|HON227.40+3.98 (+1.78%) ▲|IBM289.49-5.81 (-1.97%) ▼|INTC110.16-2.38 (-2.11%) ▼|INTU273.31-0.07 (-0.03%) ▼|ISRG403.94-7.61 (-1.85%) ▼|JNJ256.32-2.78 (-1.07%) ▼|JPM336.54+1.07 (+0.32%) ▲|KO83.35+0.72 (+0.87%) ▲|LIN531.55+5.99 (+1.14%) ▲|LLY1,183.88-33.07 (-2.72%) ▼|LMT519.46+1.20 (+0.23%) ▲|LOW213.23+0.23 (+0.11%) ▲|LRCX353.44+0.27 (+0.08%) ▲|MA521.38-1.83 (-0.35%) ▼|MCD276.75+0.26 (+0.09%) ▲|MDLZ58.72+0.42 (+0.71%) ▲|MDT83.55+1.16 (+1.41%) ▲|META668.23+36.75 (+5.82%) ▲|MMM157.80+2.46 (+1.58%) ▲|MO71.60+0.01 (+0.01%) ▲|MRK123.20-1.87 (-1.50%) ▼|MS222.61+0.48 (+0.21%) ▲|MSFT383.94-0.42 (-0.11%) ▼|MU991.99+0.35 (+0.04%) ▲|NEE87.26+0.16 (+0.18%) ▲|NFLX73.18-2.29 (-3.03%) ▼|NKE44.58+1.80 (+4.20%) ▲|NOW107.16-1.69 (-1.55%) ▼|NVDA210.20+7.42 (+3.66%) ▲|ORCL141.45-2.27 (-1.58%) ▼|PEP137.05-0.81 (-0.59%) ▼|PFE24.25+0.00 (+0.00%) ▲|PG147.09+0.24 (+0.16%) ▲|PLTR126.68-2.37 (-1.83%) ▼|PM180.81-0.36 (-0.20%) ▼|QCOM189.18-1.93 (-1.01%) ▼|RTX195.68+0.48 (+0.25%) ▲|SBUX106.96+0.55 (+0.52%) ▲|SCHW102.66+0.75 (+0.74%) ▲|SO95.34+0.17 (+0.17%) ▲|SPG215.88-3.84 (-1.75%) ▼|T21.13+0.36 (+1.75%) ▲|TMO524.82+0.11 (+0.02%) ▲|TMUS185.86+4.38 (+2.41%) ▲|TSLA409.88+3.33 (+0.82%) ▲|TXN311.48+2.95 (+0.96%) ▲|UBER74.78+0.43 (+0.58%) ▲|UNH424.78-6.90 (-1.60%) ▼|UNP288.49+3.45 (+1.21%) ▲|UPS112.67+1.93 (+1.74%) ▲|USB62.59+0.69 (+1.11%) ▲|V346.68-1.53 (-0.44%) ▼|VZ42.29+0.75 (+1.81%) ▲|WFC87.17+0.26 (+0.30%) ▲|WMT113.75+1.54 (+1.37%) ▲|XOM137.91+0.45 (+0.32%) ▲|
29.8 C
New York
Friday, July 10, 2026

Tag: research

newssourceFORcompanyinformationcontent1releasesmarket

Black Buffalo Strengthens Leadership with Kit Dietz’s Board Re-Election and Viv Penninti’s Appointment as Senior Advisor

CHICAGO, June 12, 2025 /PRNewswire/ -- Black Buffalo Inc., the leading alternative to traditional smokeless tobacco, proudly announces the re-election of Kit Dietz to...

RSM US Middle Market Business Index Reveals Early Impacts of Trade War

Survey results suggest economic pullback as middle market firms slow CapEx and hiring plans CHICAGO, June 12, 2025 /PRNewswire/ -- The RSM US Middle Market Business Index...

Vascarta Receives FDA Orphan Drug Designation for Vasceptor® in the Treatment of Sickle Cell Disease

SUMMIT, N.J., June 12, 2025 /PRNewswire/ -- Vascarta Inc., a biopharmaceutical company committed to advancing innovative therapies for underserved patient populations, announced today that...

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Vancouver, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases

Protection through 2039, ensuring long-term commercial exclusivity. NEW YORK, June 12, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative...

TripleLift Unveils Key to Retail Media Success: Creative Excellence Drives Performance in $179.5B Market

New Research Shows 82% of US Marketers Agree High-Quality Creative is Essential for KPI Outcomes, Yet Industry Focus Remains on Targeting and Data NEW YORK,...

Kandi Technologies Partners with DEEP Robotics to Expand North American Smart Golf Equipment and Security Robotics Business

JINHUA, CHINA, June 12, 2025 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) (“Kandi” or the “Company”), long renowned as a leader in all-electric personal transportation and utility vehicles, today announced a strategic collaboration with Hangzhou Yunshenchu Technology Co., Ltd. (“DEEP Robotics”), a leader in embodied AI technology innovation and application. In response to the smart-manufacturing revolution and ongoing industry digitization — and building on years of expertise in the global off-road vehicle market — Kandi is accelerating its evolution into a platform enterprise anchored by intelligent-equipment manufacturing.  Kandi’s strategy is to use its stable cashflow businesses to incubate new high growth business units that leverage technology innovation and global supply-chain excellence.

RadioMedix Debuts Proprietary bench top ²¹²Pb Generator to Support Targeted Alpha Therapy Development

New bench top ²¹²Pb generator to expand clinical-grade isotope supply for targeted alpha therapy research and development 
New bench top ²¹²Pb generator to expand clinical-grade isotope supply for targeted alpha therapy research and development

Fortrea Adopts Limited-Duration Stockholder Rights Plan

Board Committed to Protecting Long-Term Value for All Stockholders 
Board Committed to Protecting Long-Term Value for All Stockholders

CRAACO Conference Focuses on Getting More Clinical Trials Into Healthcare Systems

The Conference Forum announced the launch of the 2025 CRAACO®: Clinical Research as a Care Option event, focused on getting the option of clinical...

Hanyang University Researchers Discovered New Breakthrough Catalyst for Cheaper Green Hydrogen Production

Scientists developed a new tunable boron-doped cobalt phosphide catalyst with low cost and high efficiency for electrochemical water-splitting GYUNGGI-DO, South Korea, June 12, 2025 /PRNewswire/...

ASIAN MANUFACTURING ACTIVITY FALLS TO 17-MONTH LOW AS TARIFFS HIT CHINA-BASED SUPPLIERS: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

U.S. manufacturers front-load inventories in anticipation of further tariffsNorth American factories remain underutilized, with persistent weakness in Mexico and Canada Europe inches toward industrial...

Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases

CAMBRIDGE, Mass., June 12, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today...

Oyster Solutions To Add CAT Reporting Agent Services To CAT, CAIS Modules

Oyster Solutions Integrates CAT, CAIS and CRA Capabilities into a Unified Platform

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsResearch

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers